HOME >> BIOLOGY >> NEWS
Altadena chemist wins national award for studying life molecules

Chemist John D. Roberts of Altadena, Calif., will be honored April 3 by the world's largest scientific society for his pioneering studies in technology to better understand molecules important to life. He will receive the 2001 Nakanishi Prize from the American Chemical Society at its 221st national meeting in San Diego.

"Over the last quite a few years, my research group and I have found out much about the structures of molecules and how they work - particularly in biochemical processes," said Roberts, who is professor emeritus of chemistry at the California Institute of Technology, Pasadena.

One of his projects has been studying the action of a class of protein enzymes called proteases, the body's scissors. Despite their role in diseases such as AIDS, proteases also snip up food proteins during digestion and perform other processes critical to life.

The research tool Roberts uses is called nuclear magnetic resonance, for whose development colleagues call him a pioneer in the field. NMR is based on the principle that nuclei - those of carbon, nitrogen and so on - will vibrate at some unique frequency when placed in an energy field. Researchers use NMR to identify and analyze compounds.

Specifically, Roberts used NMR in the 1970s to learn more about why proteases are able to cut up other proteins without cutting up themselves. While many proteins fit into the protease active site, where cleavage takes place, the simple answer is that proteases do not.

But his team uncovered important details: "We showed the way in which three protease amino acids [protein subunits] in particular cooperate with each other to attack the bonds," he said, and at the same time disproved a then-popular theory of action.

Roberts continues active research despite retiring officially in 1988. He and his students are now using NMR to study "how and why certain arrangements of molecules are more favorable than others," he said.

The organic chemist received his u
'"/>

Contact: Rodney Pearson
r_pearson@acs.org
202-872-4400
American Chemical Society
3-Apr-2001


Page: 1 2

Related biology news :

1. UT Southwestern biochemist honored with NIH Directors Pioneer Award
2. NJIT chemist speaks Aug. 25 about compound derived from pine tree
3. NIH roadmap for biomedical research focus of chemists at American Chemical Society meeting
4. U of T research answers key question in biochemistry
5. Carnegie Mellon University hosts ACS-PRF summer school on green chemistry
6. Rutgers chemist uses NMR to elucidate protein-DNA interaction
7. New multidisciplinary research tops chemists meeting Aug. 22-26
8. Wisconsin chemists find a new chink in TBs armor
9. UCLA chemists develop new coating for nanoscale probes
10. High profile publications in biology and biochemistry on rise at UH
11. Biochemist becomes 15th UT Southwestern faculty member serving on National Academy of Sciences

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Altadena chemist wins national award for studying life molecules

(Date:4/1/2015)... , April 1, 2015   Medisafe ™, the ... users across iOS and Android ... integrating biofeedback into the platform to allow patients to ... For the first time, patients will be able to ... dose impacts important biometrics, such as glucose levels and ...
(Date:3/31/2015)... NEW YORK , March 31, 2015   ... announced the launch of the Post-Surgical Pain Management TRACKER, ... data products tracking usage trends in the medical device ... monthly access to data including treatment volumes, market share, ... manage the pain associated with joint surgery. ...
(Date:3/26/2015)... TORONTO , March 26, 2015 ... premier family, social, recreation and athletic club, today announced ... designed to allow freedom of movement for members and ... "Following a comprehensive process, we selected FST,s IMID ... sophistication and convenience for our members and staff, in ...
Breaking Biology News(10 mins):Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2
(Date:4/20/2015)... British Columbia and MENLO ... --  DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) (DelMar ... developing and commercializing proven cancer therapies in new ... at the 106th Annual Meeting of the ... Meeting on the potential for its lead product ...
(Date:4/20/2015)... , April 20, 2015  Eli Lilly and ... data from several targeted cancer therapies, reflecting Lilly,s diverse ... (AACR) Annual Meeting 2015, held April 18-22 in ... Cancer Discoveries to Patients" is the theme of this ... Lilly,s commitment to broadening its portfolio of therapies that ...
(Date:4/20/2015)... --  Meditope Biosciences, Inc ., a biotechnology company developing ... presentation of data demonstrating the use of its SnAP ... data were presented in an abstract at the AACR ... Philadelphia . "We are ... many commercial applications that may be possible for our ...
(Date:4/17/2015)... Reed Technology and Information Services Inc. ... and submission to the U.S. Food and Drug Administration ... Distribution Report (LDR) service for manufacturers of biologics, including ... FDA’s new rule on electronic submission of LDRs. ... and timing of particular biologics introduced to the marketplace, ...
Breaking Biology Technology:DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 2DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 3DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 4DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 5Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 2Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 3Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 4Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 5Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 6Meditope Biosciences Presents Data At The American Association Of Cancer Research (AACR) Annual Meeting Validating Its SnAP Technology Platform 2Reed Tech Announces FDA Lot Distribution Report (LDR) Service for Manufacturers of Biologic Products 2Reed Tech Announces FDA Lot Distribution Report (LDR) Service for Manufacturers of Biologic Products 3
Cached News: